Scientific Advisory Board

OptoQuest has assembled the following Scientific Advisory Board to assist with the overall vision of our technologies and direction of our company. We are very pleased and humbled to have such a diverse group of talented and knowledgeable individuals assisting us in our operations.

Richard Lindstrom, MD

Dr. Richard L. Lindstrom, founder and attending surgeon of Minnesota Eye Consultants and Adjunct Professor Emeritus at the University of Minnesota Department of Ophthalmology, is a board-certified ophthalmologist and internationally recognized leader in corneal, cataract, refractive and laser surgery. He has been at the forefront of ophthalmology's evolutionary changes throughout his career, as a recognized researcher, teacher, inventor, writer, lecturer and highly acclaimed physician and surgeon.

After graduating Magna Cum Laude from the College of Liberal Arts at the University of Minnesota, Dr. Lindstrom completed his doctorate degree in medicine in 1972. He conducted research, residency and fellowship training in cornea at the University of Minnesota and affiliated hospitals and extended his anterior segment surgery fellowship training at Mary Shiels Hospital in Dallas and was a Heed Fellow in Glaucoma at University Hospital in Salt Lake City. In 1980, Dr. Lindstrom returned to the University of Minnesota, where he spent ten years on the faculty of the Department of Ophthalmology, the last two as a full professor and the Harold G. Scheie Research Chair. He continues as Adjunct Professor Emeritus, Chairman of the Vision Foundation, and Associate Director of the Minnesota Lions Eye Bank at the University of Minnesota. He entered private practice in 1989, and has led the growth and expansion of Minnesota Eye Consultants serving as managing partner for 15 years. He is also Medical Director of TLC Vision, Sightpath Medical, and Refractec. He is Chief Medical Editor of the USA and International editions of Ocular Surgery News, which reaches 82,000 ophthalmologists worldwide.

Brad Randleman, MD

J. Bradley Randleman, MD, is an international leader in corneal and intraocular refractive surgical procedures, the management of corneal and external eye diseases and corneal transplantation. His primary research interests include diagnosis, prevention, and management of refractive surgical complications.

Dr. Randleman joined the Emory Eye Center faculty in 2004 and served as Assistant Residency Director for two years while also completing a fellowship at Emory University in cornea/external disease and refractive surgery. He serves as Service Director for the section of Cornea, External Disease and Refractive Surgery and is Editor in Chief of the Journal of Refractive Surgery. He is one of the world’s leading authorities in post-refractive surgery ectasia and associated risk factors.

A. John Kanellopoulos, MD

Dr. Kanellopoulos received his Medical Degree in 1990 from the Southern Illinois University and completed his ophthalmology residency at the State University of New York Stony Brook in 1994. He then trained in External Diseases, Cornea and Refractive surgery at Cornell University Medical College and Massachusetts Eye and Ear Infirmary, Harvard Medical School, and completed a Glaucoma Fellowship at Harvard Medical School.

Over the last 20 years he has taken a particular interest in the management of irregular corneal topography due to conditions such as keratoconus. In 2005, his team introduced the “Athens Protocol”, a combination treatment of topography-guided PRK and collagen cross-linking as an alternative treatment for keratoconus and ectasia. He specializes in refractive surgery, corneal transplantation and high-risk cataract surgery. He currently serves as Medical Director of the Laservision.gr Institute, Athens, Greece. Since 2010 he has served as Clinical Professor in the Department of Ophthalmology at the New York University Medical School. He has been a clinical consultant for several sites in the United States and Europe. He has published over 35 original papers in peer-reviewed journals, over 15 book chapters and hundreds of paper and poster presentations at major eye meetings worldwide. Since 2009 he has served as a member of the ASCRS Clinical Cornea Committee, and since 2010 as a member of the Executive Committee of the American Academy of Ophthalmology/ISRS. In 2011 he was selected for the Lans Distinguished Award from ISRS/AAO for innovative work in refractive surgery. Recently, he has helped to pioneer the concept of customized corneal collagen crosslinking in collaboration with OptoQuest and Avedro.

Ronald Krueger, MD

Ronald Krueger, MD, is Medical Director of Refractive Surgery at the Cleveland Clinic Cole Eye Institute and has performed over fifteen thousand refractive surgery procedures. He has authored more than 100 peer-reviewed manuscripts and many more abstracts, book chapters and trade journal articles. He has over two decades of experience in excimer laser research, including the first physical descriptions of the effects of the excimer lasers on corneal tissue and many more developments, including the early principles of ocular wavefront customized laser vision correction.

To this end, Dr. Krueger has co-organized an international congress on Ocular Wavefront Customization for the past 13 years and co-authored the first book on the subject, "Customized Corneal Ablation: The Quest for Super-Vision," which was later followed by a second edition. He also has more than 10 years of research experience in ultrashort pulse laser photodisruption of ocular tissue and is involved in research investigating the causes of presbyopia and restoration of accommodation.

He was a former Secretary of Education and board member of the International Society of Refractive Surgery (ISRS) prior to its merger with the AAO, and served on both the executive and program committees of the ISRS/AAO. He has been the Associate Editor for the Journal of Refractive Surgery for more than 12 years, and he has lectured on refractive surgery in over 40 nations. He is the current President of the ISRS.

David Muller, PhD, MBA

Dr. Muller, a proven serial entrepreneur, recognized the potential of using advanced methods to gently reshape the cornea and in 2007 founded Avedro, Inc., where he serves as CEO. Under his direction, Avedro has pioneered numerous advances in the field of cross-linking, including Accelerated Cross-Linking, pulsed illumination, Lasik Xtra®, and Photorefractive Intrastromal Cross-Linking (PiXL™). Previously, as the founder, Chairman of the Board and CEO of Summit Technology, Dr. Muller led the team that brought the first FDA-approved excimer laser to market and laser vision correction eye surgery to tens of millions of people around the world. He is the author of publications in the areas of photochemistry and excimer laser development, as well as the inventor of numerous patents in the medical device field. In addition, he has established companies in other industries, including internet commerce, homeland security and specialty foods. Dr. Muller earned a doctorate in Physical Chemistry from Cornell University and an MBA from The Wharton School of the University of Pennsylvania.

Peter Kaiser, MD

Peter K. Kaiser, MD, is a Staff member of the vitreoretinal faculty of the Cole Eye Institute in the Department of Ophthalmology at Cleveland Clinic's main campus. He was appointed in 1997. Dr. Kaiser is the Founding Director of the Digital Optical Coherence Tomography (OCT) Reading Center, which is one of the largest OCT coordinating centers in the world and has been the reading center for over 40 trials. Dr. Kaiser received his medical degree magna cum laude from Harvard Medical School in Boston, Mass. He completed an internship in internal medicine at Massachusetts General Hospital, an ophthalmology residency at the Massachusetts Eye and Ear Infirmary in Boston and a retinal fellowship at Bascom Palmer Eye Institute in Miami, Florida.

Actively involved in retinal clinical research, Dr. Kaiser is study chairman of four major, multi-center, international clinical trials and is a principal investigator in multiple other trials. Complementing his research endeavors, Dr. Kaiser serves on numerous scientific advisory boards and is in high demand as an invited speaker at national and international conferences. Dr. Kaiser is a major contributor to medical literature, having authored several ophthalmology texts and more than 200 book chapters, original reports, electronic publications and abstracts. He is an associate editor of the American Journal of Ophthalmology, and serves on the editorial boards of Retina, Retina Today, Retinal Physician and Ocular Surgery News. Dr. Kaiser is also the technical lead for the Cole Eye Institute Ophthalmic Imaging Center.